Focus: Inotiv is a public biotechnology company providing contract laboratory services and scientific instruments to the pharmaceutical industry. Based in West Lafayette, IN, they operate as a specialized service provider with $572M in annual revenue.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Growing — net +14 jobs in 30d
39 jobs added vs 25 removed. Steady team buildout.
Best suited for scientists seeking stable service-provider roles with exposure to industry workflows; less ideal for those pursuing drug development or equity upside.
Single marketed asset with limited commercial scale, positioned as a secondary revenue contributor rather than portfolio driver.
Help build intelligence for Inotiv
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Inotiv's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data.
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma.
Showing 5 of 10 publications